We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-27.88%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$1.32B
AUM Growth
-$346M
Cap. Flow
-$15.1M
Cap. Flow %
-1.15%
Top 10 Hldgs %
59.82%
Holding
111
New
34
Increased
24
Reduced
9
Closed
40

Top Buys

Rank Stock Value
1
CLVS
Clovis Oncology, Inc.
CLVS
+$69.5M
2
ENR icon
Energizer
ENR
+$56.7M
3
SRCL
Stericycle Inc
SRCL
+$40.3M
4
SGI
Somnigroup International
SGI
+$34.7M
5
WBT
Welbilt, Inc.
WBT
+$27.1M

Top Sells

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$37.3M
2
HOG icon
Harley-Davidson
HOG
+$37.3M
3
HBI
Hanesbrands
HBI
+$36.9M
4
CPRI icon
Capri Holdings
CPRI
+$36.7M
5
CAR icon
Avis
CAR
+$32.1M

Sector Composition

Rank Sector Weight
1 Healthcare 38.78%
2 Consumer Discretionary 11.57%
3 Industrials 7.52%
4 Consumer Staples 5.7%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OVID icon
51
Ovid Therapeutics
OVID
$420M
$3.87M 0.29%
+1,600,000
New +$7.3M
CENN icon
52
Cenntro
CENN
$8.09M
$3.26M 0.25%
4
+2
+100% +$2.52M
CPRX
53
DELISTED
Catalyst Pharmaceutical
CPRX
$2.65M 0.2%
1,380,000
-292,000
-17% -$836K
ASMB icon
54
Assembly Biosciences
ASMB
$502M
$2.26M 0.17%
+8,333
New +$2.41M
SRRA
55
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$2.11M 0.16%
+40,000
New +$2.55M
MDGSW
56
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$1.75M 0.13%
+1,285,715
New +$874K
ORMP icon
57
Oramed Pharmaceuticals
ORMP
$168M
$1.63M 0.12%
542,944
-81,056
-13% -$336K
DYNT
58
DELISTED
Dynatronics Corp
DYNT
$1.53M 0.12%
112,200
+1,991
+2% +$27.2K
ROX
59
DELISTED
Castle Brands, Inc.
ROX
$886K 0.07%
1,042,000
+942,000
+942% +$867K
SEEL
60
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$883K 0.07%
40
– –
CTXR icon
61
Citius Pharmaceuticals
CTXR
$15.8M
$768K 0.06%
29,537
+27,200
+1,164% +$931K
ACHV icon
62
Achieve Life Sciences
ACHV
$650M
$542K 0.04%
+22,400
New +$845K
UAA icon
63
Under Armour
UAA
$2.84B
$530K 0.04%
+30,000
New +$616K
PULM icon
64
Pulmatrix
PULM
$6.35M
$414K 0.03%
+8,616
New +$635K
TOVX icon
65
Theriva Biologics
TOVX
$9.69M
$312K 0.02%
+2,228
New +$529K
PALI icon
66
Palisade Bio
PALI
$327M
$185K 0.01%
+7
New +$402K
TENX icon
67
Tenax Therapeutics
TENX
$389M
$102K 0.01%
+53
New +$291K
AYTU icon
68
AYTU BioPharma
AYTU
$23.5M
$79K 0.01%
+500
New +$110K
TRAW icon
69
Traws Pharma
TRAW
$6.74M
$62K ﹤0.01%
78
-219
-74% -$373K
AIXC
70
AIxCrypto Holdings Inc
AIXC
$13.4M
$30K ﹤0.01%
4
-11
-73% -$158K
BBY icon
71
Best Buy
BBY
$18.3B
– –
-200,000
Closed -$15.9M
BLUE
72
DELISTED
bluebird bio
BLUE
– –
-6,794
Closed -$12.8M
CAKE icon
73
CALL
Cheesecake Factory
CAKE
$5.1B
– –
-1,100,000
Closed -$58.9M
CAR icon
74
Avis
CAR
$4.84B
– –
-1,000,000
Closed -$32.1M
CPB icon
75
CALL
Campbell Soup
CPB
$6.57B
– –
-2,000,000
Closed -$73.3M
1 2
3
4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

Armistice Capital's Q4 2018 Portfolio in Review

As of Q4 2018, Armistice Capital held 111 positions worth $1.32B, down 21% from $1.67B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Armistice Capital's Q4 2018 filing shows 34 new, 24 increased, 9 reduced and 40 closed positions. Its largest new stake was Energizer: 1,068,000 shares worth $48.2M. The largest sale was United Therapeutics, an estimated $37.3M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 37% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Armistice Capital's largest Q4 2018 buy was Energizer: 1,068,000 shares worth $48.2M.
  • Armistice Capital added most to Clovis Oncology, Inc. in Q4 2018, an estimated $69.5M increase.
  • Armistice Capital's biggest Q4 2018 reduction was J.M. Smucker, cutting an estimated $28.8M.
  • Armistice Capital fully exited United Therapeutics in Q4 2018, selling an estimated $37.3M.
  • Armistice Capital's ten largest holdings make up 60% of its $1.32B portfolio in Q4 2018.
  • Armistice Capital opened 34 new positions and closed 40 in Q4 2018.
  • Armistice Capital's portfolio value fell 21% quarter-over-quarter to $1.32B.

Based on Armistice Capital's 13F filing for Q4 2018, filed 14 Feb 2019.